VICTORIA HILL: Open Payments
NPI 1700858206 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 29 payments from 17 companies in 2025. Trend: 2023 $59 · 2024 $329 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $157 |
| Celgene Corporation | 4 | $99 |
| Agios Pharmaceuticals, Inc. | 2 | $44 |
| PharmaEssentia USA Corporation | 2 | $44 |
| TerSera Therapeutics LLC | 2 | $35 |
| Lilly USA, LLC | 1 | $34 |
| Iovance Biotherapeutics, Inc. | 1 | $28 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| Exelixis Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: REBLOZYL, WELIREG, KEYTRUDA, PYRUKYND, BESREMI, Zoladex, VERZENIO, Amtagvi.
Industry payments across FL — which companies pay providers there.
